Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Q3 Revenues Double, Losses Narrow

NEW YORK, Oct. 22 (GenomeWeb News) – Luminex today reported increased net revenues for the third quarter, and significantly narrowed net losses.

The Austin, Texas company, which makes the xMap bead assay system for genomics and proteomics research and other applications, reported revenues of $7.2 million for the quarter, compared to $3.6 million for the third quarter of 2002. Net losses for the quarter came to $.9 million, compared to $5.8 million for the same period last year.

The company's R&D expenses decreased to $.7 million, from $1.2 million for the year-ago period.

As of Sept. 30, Luminex had $40.2 million in cash and cash equivalents.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.